Home » Topics » BioWorld Science

BioWorld Science
RSS

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Jan. 21, 2022

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Jan. 21, 2022

Alpha Tau enters sponsored research agreement with MD Anderson to study Alpha DaRT in breast cancer

Jan. 21, 2022

Targeting HO-1 signaling pathway against dengue hemorrhagic fever

Jan. 21, 2022

Researchers develop novel murine model of age-related macular degeneration

Jan. 21, 2022

Gene silencing using Toc-HDO technology ameliorated symptoms in EAE models

Jan. 21, 2022

New three-prime repair exonuclease 1 inhibitors described by Tempest Therapeutics

Jan. 21, 2022

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

Jan. 21, 2022

New macrophage migration inhibitory factor inhibitors identified at Immunophage Biomedical

Jan. 21, 2022

New TRPA1 antagonists discovered at Boehringer Ingelheim

Jan. 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...